Conditions: Antivirals/HIV
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 85
Healthy volunteers: yes

Brief summary:
The purpose of this study is to evaluate the exposure of rifabutin (RIB) when administered with atazanavir and ritonavir (ATV/RTV)

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Rifabutin intervention 2: Rifabutin + Atazanavir + Ritonavir
Intervention descriptions: intervention 1: Capsule, Oral, 150 mg, once daily, 11 Days intervention 2: Capsules, Oral, 18 Days

Rifabutin (150 mg, 2x/wk)

Atazanavir (300 mg, once daily)

Ritonavir (100 mg, once daily)

Protocol document: